1. Home
  2. VERU vs PPIH Comparison

VERU vs PPIH Comparison

Compare VERU & PPIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERU
  • PPIH
  • Stock Information
  • Founded
  • VERU 1971
  • PPIH 1993
  • Country
  • VERU United States
  • PPIH United States
  • Employees
  • VERU N/A
  • PPIH N/A
  • Industry
  • VERU Biotechnology: Pharmaceutical Preparations
  • PPIH Pollution Control Equipment
  • Sector
  • VERU Health Care
  • PPIH Industrials
  • Exchange
  • VERU Nasdaq
  • PPIH Nasdaq
  • Market Cap
  • VERU 107.2M
  • PPIH 128.3M
  • IPO Year
  • VERU 1990
  • PPIH N/A
  • Fundamental
  • Price
  • VERU $0.74
  • PPIH $14.35
  • Analyst Decision
  • VERU Strong Buy
  • PPIH
  • Analyst Count
  • VERU 4
  • PPIH 0
  • Target Price
  • VERU $4.00
  • PPIH N/A
  • AVG Volume (30 Days)
  • VERU 1.6M
  • PPIH 52.1K
  • Earning Date
  • VERU 02-06-2025
  • PPIH 12-23-2024
  • Dividend Yield
  • VERU N/A
  • PPIH N/A
  • EPS Growth
  • VERU N/A
  • PPIH 213.23
  • EPS
  • VERU N/A
  • PPIH 1.98
  • Revenue
  • VERU $16,886,419.00
  • PPIH $153,576,000.00
  • Revenue This Year
  • VERU N/A
  • PPIH N/A
  • Revenue Next Year
  • VERU N/A
  • PPIH N/A
  • P/E Ratio
  • VERU N/A
  • PPIH $7.24
  • Revenue Growth
  • VERU 3.62
  • PPIH 4.52
  • 52 Week Low
  • VERU $0.36
  • PPIH $6.83
  • 52 Week High
  • VERU $1.92
  • PPIH $17.58
  • Technical
  • Relative Strength Index (RSI)
  • VERU 56.66
  • PPIH 43.47
  • Support Level
  • VERU $0.63
  • PPIH $16.57
  • Resistance Level
  • VERU $0.88
  • PPIH $17.50
  • Average True Range (ATR)
  • VERU 0.09
  • PPIH 1.16
  • MACD
  • VERU 0.00
  • PPIH -0.18
  • Stochastic Oscillator
  • VERU 49.11
  • PPIH 30.00

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology and acute respiratory distress syndrome (ARDS). The company is also in the late stage development of certain drugs for management of breast and prostate cancers. It also has a sexual health program which includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in single segment and generates revenue from USA which is the key revenue generating market, South Africa and other regions.

About PPIH Perma-Pipe International Holdings Inc.

Perma-Pipe International Holdings Inc is engaged in the manufacture and sale of products in the reportable segment of Piping Systems. The company engineers, designs, manufactures and sells specialty piping systems and leak detection systems. Specialty piping systems include insulated and jacketed district heating and cooling piping systems for efficient energy distribution from central energy plants to multiple locations, primary and secondary containment piping systems for transporting chemicals, hazardous fluids and petroleum products, and the coating and insulation of oil and gas gathering and transmission pipelines. It operates in the United States, Canada, Middle East, Europe, India and other countries.

Share on Social Networks: